Photosensitising Potency of Benzoporphyrin Derivative Analogues in Mice
Author Information
Author(s): A.M. Richter, E. Waterfield, A.K. Jain, B. Allison, E.D. Sternberg, D. Dolphin, J.G. Levy
Primary Institution: University of British Columbia
Hypothesis
The study investigates the in vivo characteristics and photosensitising potency of four analogues of benzoporphyrin derivative (BPD) in a mouse tumour model.
Conclusion
The monoacid forms of BPD were found to be significantly more effective in photosensitisation than the diacid analogues.
Supporting Evidence
- The biodistribution studies showed that BPD-MA accumulated in liver, spleen, and kidneys at higher concentrations than in the tumor.
- BPD-MA and BPD-MB were measurably better than the diacid analogues in tumor ablation.
- Monoacid forms were at least five times as potent as diacid forms in photosensitisation of tumor cells.
Takeaway
This study tested different versions of a cancer treatment drug in mice to see which one worked best at killing tumor cells when exposed to light.
Methodology
The study involved synthesizing BPD analogues, injecting them into DBA/2J mice, and assessing their biodistribution and photosensitising activity in a tumor model.
Limitations
The study primarily focused on a limited number of analogues and may not represent all possible variations of BPD.
Participant Demographics
DBA/2J mice, 8 to 12 weeks old, both male and female used.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website